Yungjin Pharm. Market Cap

Yungjin Pharm. has a market cap or net worth of 361.40 billion as of March 28, 2025. Its market cap has decreased by -2.42% in one year.

Market Cap

361.40B

Enterprise Value

n/a

Revenue

158.79B

Ranking

n/a

PE Ratio

36.94

Stock Price

1,976.00

Market Cap Chart

Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 361.40B, an increase of 484.75%. That is a compound annual growth rate of 5.68%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	361.40B	-0.60%
Dec 30, 2024	363.59B	-6.45%
Dec 28, 2023	388.65B	-34.62%
Dec 29, 2022	594.40B	-38.56%
Dec 30, 2021	967.50B	-34.20%
Dec 30, 2020	1,470.46B	21.27%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.66T
Celltrion	38.03T
ALTEOGEN	18.79T
Yuhan	8,537.79B
SK Biopharmaceuticals	7,893.98B
HLB Co., Ltd.	7,500.72B
Sam Chun Dang Pharm.	3,930.51B
PharmaResearch	3,506.51B

Market Cap Rankings